Cargando…
Ligand-Directed Functional Selectivity at the Mu Opioid Receptor Revealed by Label-Free Integrative Pharmacology On-Target
Development of new opioid drugs that provide analgesia without producing dependence is important for pain treatment. Opioid agonist drugs exert their analgesia effects primarily by acting at the mu opioid receptor (MOR) sites. High-resolution differentiation of opioid ligands is crucial for the deve...
Autores principales: | Morse, Megan, Tran, Elizabeth, Sun, Haiyan, Levenson, Robert, Fang, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189208/ https://www.ncbi.nlm.nih.gov/pubmed/22003401 http://dx.doi.org/10.1371/journal.pone.0025643 |
Ejemplares similares
-
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
por: Morse, Megan, et al.
Publicado: (2013) -
Divergent Label-free Cell Phenotypic Pharmacology of Ligands at the Overexpressed β(2)-Adrenergic Receptors
por: Ferrie, Ann M., et al.
Publicado: (2014) -
Label-free integrative pharmacology on-target of drugs at the β(2)-adrenergic receptor
por: Ferrie, Ann M., et al.
Publicado: (2011) -
Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013) -
Activity of opioid ligands in cells expressing cloned mu opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2003)